Clinical Trial Update: Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients [NA]

View source ↗

Summary

Clinical trial update for Vivatmo Pro FeNO monitoring in U.S. asthma patients shows completed status with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Vivatmo Pro

Snippet

Sponsor: Bosch Healthcare Solutions GmbH | Conditions: Asthma, Asthma in Children | NA | Status: COMPLETED | Results posted: 2022-06-06